Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nefopam in Postoperative Pain After Laparotomy
NCT02596269Phase 3Completed
- Sponsor
- Seoul National University Hospital
- Start
- Oct 2012
- Primary completion
- Sep 2013
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of nefopam in postoperative pain, sponsored by Seoul National University Hospital. Primary endpoint: Cumulative fentanyl consumption at 24 hours. Started Oct 2012; status: completed.
02
Drugs
nefopam
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02596269.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02596269.